Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Hemodynamic Monitoring Systems Market By Product By Distribution Channel and Geography
Hemodynamic Monitoring Systems Market By Product By Distribution Channel and Geography
Hemodynamic Monitoring Systems Market was valued at US$ 1,167.3 million in 2023 and is expected to grow at a 5.0% CAGR from 2024 to 2030. Hemodynamic monitoring involves measuring blood circulation and cardiac function parameters to assess a patient's cardiovascular health. Cardiovascular diseases are the main cause of death globally, Annually, cardiovascular diseases (CVDs) claim the lives of approximately 17.9 million people, making them the leading cause of death worldwide, accounting for 31% of all global deaths. Increasing Prevalence of Cardiovascular Diseases (CVD) and Diabetes drives the Hemodynamic Monitoring Systems market.
Additionally, advancements in technology have revolutionized patient care through non-invasive hemodynamic monitoring technologies. These innovations provide accurate measurements without the need for costly, complex, and invasive procedures. Furthermore, an increasing number of mergers, acquisitions, and product launches among the manufacturers and market players to provide medical care to patients are expected to result in the expansion of the Hemodynamic Monitoring Systems Market over the forecast period. For instance, Masimo acquired LiDCO Group in January 2021, expanding its hemodynamic monitoring capabilities. This acquisition allows Masimo to offer clinicians a broader range of advanced patient monitoring solutions.
However, Limited Awareness and Skilled Professionals are significant barriers to the widespread adoption of hemodynamic monitoring and unawareness of the benefits of hemodynamic tracking. Ambulatory care is gaining traction in hemodynamic monitoring due to portable and wearable devices. These technologies enable continuous patient monitoring outside hospitals, allowing for more flexible and convenient care.
In 2019, Baxter acquired Cheetah Medical. The underlying reasons for the acquisition were:
In May 2024, Medically Home collaborated with Siemens Healthineers. The underlying reasons for the collaboration were:
Study Period
2024-2030Base Year
2023CAGR
5.0%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The rising prevalence of cardiovascular diseases drives the hemodynamic monitoring system market. These systems are crucial for managing acute and chronic heart conditions, providing real-time data on cardiac output and blood pressure. With cardiovascular diseases being the leading global cause of death, accounting for 31% of all deaths worldwide, the demand for hemodynamic monitoring is increasing. The aging population further contributes to this trend. Additionally, growing awareness among healthcare professionals about the importance of continuous monitoring in critical care settings boosts market growth. Technological advancements and evidence-based guidelines supporting these systems' use have also increased their adoption in healthcare facilities.
The North America Hemodynamic Monitoring Systems Market accounted for the largest share of the market holding 52.2% of the total market share and is expected to retain its dominance in forecasted years. Early implementation of home-based and remote monitoring solutions & rapid acceptance patient monitoring beyond hospital confines, utilizing cutting-edge technologies for continuous cardiovascular assessment in domestic settings. Additionally, the presence of industry leaders further solidifies North America's preeminent position in this market. Europe is likely to grow at a CAGR of 4.7%, it’s because of increased adoption of innovative technologies in healthcare settings, also Healthcare providers are embracing advanced monitoring systems that offer improved accuracy, real-time data analysis, and integration with electronic health records.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,167.3 million |
|
Market CAGR |
5.0% |
|
By Product Type |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The Hemodynamic Monitoring Systems Market was valued at US$ 1,167.3 million in 2023 and is expected to grow at a 5.0% CAGR from 2024 to 2030.
The hemodynamic monitoring systems market key players are LiDCO Group plc (U.K.) PULSION Medical Systems SE (Germany) Deltex Medical Group Plc. (U.K.) Cheetah Medical Inc. (Israel) Hemo Sapiens Inc. (U.S.) Osypka Medical GmbH (Germany)
The hemodynamic monitoring systems market regions are North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global Hemodynamic Monitoring Systems Market Introduction |
| 2.1.Global Hemodynamic Monitoring Systems Market - Taxonomy |
| 2.2.Global Hemodynamic Monitoring Systems Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3.Global Hemodynamic Monitoring Systems Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Hemodynamic Monitoring Systems Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Hemodynamic Monitoring Systems Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Classic Monitoring (Invasive and Minimal Invasive) |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Smart Monitoring |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Capital Platforms (Monitors) |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Hemodynamic Monitoring Systems Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Diagnostic Centres |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospitals |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Catheterization Laboratories |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Hemodynamic Monitoring Systems Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Hemodynamic Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Classic Monitoring (Invasive and Minimal Invasive) |
| 8.1.2.Smart Monitoring |
| 8.1.3.Capital Platforms (Monitors) |
| 8.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Diagnostic Centres |
| 8.2.2.Hospitals |
| 8.2.3.Catheterization Laboratories |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Hemodynamic Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Classic Monitoring (Invasive and Minimal Invasive) |
| 9.1.2.Smart Monitoring |
| 9.1.3.Capital Platforms (Monitors) |
| 9.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Diagnostic Centres |
| 9.2.2.Hospitals |
| 9.2.3.Catheterization Laboratories |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Hemodynamic Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Classic Monitoring (Invasive and Minimal Invasive) |
| 10.1.2.Smart Monitoring |
| 10.1.3.Capital Platforms (Monitors) |
| 10.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnostic Centres |
| 10.2.2.Hospitals |
| 10.2.3.Catheterization Laboratories |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Hemodynamic Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Classic Monitoring (Invasive and Minimal Invasive) |
| 11.1.2.Smart Monitoring |
| 11.1.3.Capital Platforms (Monitors) |
| 11.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnostic Centres |
| 11.2.2.Hospitals |
| 11.2.3.Catheterization Laboratories |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Hemodynamic Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Classic Monitoring (Invasive and Minimal Invasive) |
| 12.1.2.Smart Monitoring |
| 12.1.3.Capital Platforms (Monitors) |
| 12.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnostic Centres |
| 12.2.2.Hospitals |
| 12.2.3.Catheterization Laboratories |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Masimo Corporation |
| 13.2.2.Deltex Medical Edwards Lifesciences |
| 13.2.3.Canon Inc. |
| 13.2.4.Getinge |
| 13.2.5.OSYPKA MEDICAL |
| 13.2.6.ICU Medical |
| 13.2.7.Abbott |
| 13.2.8.Philips |
| 13.2.9.Siemens Healthineers |
| 13.2.10.GE Healthcare |
| 13.2.11.Change Healthcare |
| 13.2.12.Baxter |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.